Mechanistic basis for improved activity of Engineered AsCas12a.

Linnea Jansson-Fritzberg1, Bryant Chica1, Chrysa Latrick1,2

  • 1Editas Medicine, Inc, Cambridge, MA, USA.

Communications Biology
|March 11, 2026
PubMed
Summary

Engineered CRISPR-Cas12a variants show enhanced DNA cleavage potency by reducing protein-DNA interactions, improving R-loop formation for precise gene editing. This research aids in designing more efficient and specific genome-editing tools.